BP1141
Glimepiride for system suitability
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 93479-97-1
Synonym(S): Glimepiride
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | BP1141-25-MG | In Stock | ₹ 27,365.60 |
BP1141 - 25 MG
In Stock
Quantity
1
Base Price: ₹ 27,365.60
GST (18%): ₹ 4,925.808
Total Price: ₹ 32,291.408
grade
pharmaceutical primary standard
form
solid
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)C1=O
InChI
1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-
InChI key
WIGIZIANZCJQQY-RUCARUNLSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Selleck Chemical LLC Glimepiride 200mg 93479-97-1 | -- | ₹ 10,359.60 | ||
Glimepiride Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 20,737.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Glimepiride United States Pharmacopeia (USP) Reference Standard | 93479-97-1 | MFCD00878417 | 200MG | -- | ₹ 72,778.86 | ||
Sigma Aldrich Fine Chemicals Biosciences Glimepiride >=98% (HPLC), solid | 93479-97-1 | MFCD00878417 | 250MG | -- | ₹ 83,175.84 | ||
Sigma Aldrich Fine Chemicals Biosciences Glimepiride for system suitability European Pharmacopoeia (EP) Reference Standard | 93479-97-1 | MFCD00878417 | | -- | ₹ 17,007.90 | ||
Sigma Aldrich Fine Chemicals Biosciences Glimepiride British Pharmacopoeia (BP) Reference Standard | 93479-97-1 | MFCD00878417 | | -- | ₹ 28,455.97 | ||
Glimepiride | -- | ₹ 19,160.25 | ||
Glimepiride | -- | ₹ 71,726.45 | ||
Glimepiride | -- | ₹ 14,267.35 | ||
93479-97-1 | Glimepiride | -- | ₹ 890.00 - ₹ 35,422.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Glimepiride for system suitability BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.
- Biochem/physiol Actions: Glimepiride is a potent blocker of cardiac KATP channels activated by pinacidil with an IC50 of 6.8 nM.
- Packaging: Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Repr. 2
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable